We're committed to providing you with the very best cancer care, and your safety continues to be a top priority. With this in mind, we’ve put in place many new procedures, including a limited visitor policy. This is just one more way of ensuring your safety and that of our staff. Read more
The focus of our research is to understand the global genetic determinants of cancer development and therapeutic response. We primarily utilize data generated by next-generation sequencing technologies to study genomic mutations, copy number alterations, structural variations, and transcriptome changes, which together provide a molecular profile of individual tumors.
We collaborate closely with clinical investigators and researchers to integrate molecular and clinical information so as to identify molecular determinants of clinical phenotypes, thereby allowing more precise stratification of patient populations and targeting of cancer therapeutics.